Alcon Inc
ALC: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$89.00 | Pdlzkz | Clbtcckj |
Alcon's Solid Execution and New Innovation Spark Market Penetration and Long-Term Growth
Business Strategy and Outlook
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: vision care and surgical.